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Abstract: Understanding the global gene expression profile of stem cells and their multilineage differentiation will be es-
sential for their ultimate therapeutic application. Efforts to characterize stem cells have relied on analyzing the genome-
wide expression profiles that are biased towards the identification of genes that display the most pronounced differential 
expression. Rather than being viewed as a “blank” state, recent studies suggest that stem cells express low levels of multi-
ple lineage specific genes prior to differentiation, a phenomenon known as “lineage priming.” It is not likely that low lev-
els of lineage-specific genes produce sufficient amounts of differentiation factors, but rather to provide rapid transcription 
to a wide range of lineage programs prior to differentiation. Thus, stem cell differentiation may involve the elimination of 
other potential pathways and the activation of a specific lineage program.  
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INTRODUCTION 
  The goal of regenerative medicine is to replace or restore 
normal function of cells, tissues, and organs that are dam-
aged by disease. While progenitor cells are recognized as the 
ideal transplantation resource, cells obtained from diseased 
organs (congenital, cancerous or age-related effects) may not 
be appropriate for tissue engineering purposes. Furthermore, 
some primary cells cannot be expanded from particular or-
gans, such as the pancreas and brain. In these situations, 
stem cells are envisioned as an alternative source of cells 
from which the desired tissue can be produced. Stem cells 
represent a source of versatile cells with the potential to re-
place diseased tissues and organs.  
  According to data from the Centers for Disease Control, 
as many as 1 million Americans will die every year from 
disease that, in the future, may be treatable with cells derived 
from stem cells [1]. Diseases that might benefit from embry-
onic stem cell-based therapies included diabetes, heart dis-
ease, cerebrovascular disease, liver and renal failure, spinal 
cord injuries and Parkinson’s disease. The types of stem cells 
fall into three categories: embryonic, fetal and adult stem 
cells. Embryonic stem cells (ES cells) have the ability to 
grow indefinitely and differentiate into cells of all three germ 
layers. On the other hand, fetal stem cells are easily accessi-
ble and do not require technical manipulations, but they may 
not be as nimble as ES cells. Adult stem cells have a limited 
growth and differentiation potential. However, this is advan- 
tageous because they have a lower tendency to form tumors 
and mixed phenotypes.  
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  Despite the knowledge gained by stem cells’ ability to 
differentiate into multiple lineages, very little is known about 
the genes that govern the special properties of stem cells. 
Concerns about the clinical potential of stem cells include 
the quality of stem cell derivatives, the specificity of differ-
entiation, and their tendency to form heterogeneous cell 
types. Understanding the molecular signature of stem cells 
will enable the control and direction of differentiation into 
particular phenotypes. Analysis of stem cell differentiation 
requires the expression of transcription factors and lineage-
specific genes. However, it is becoming more important to 
test for negative markers of differentiation (whether stem 
cell-specific genes or other lineage-specific genes). Because 
of the recent advances of microarray technology, a non-
biased view of the transcriptional status of stem cells and 
their derivatives can be determined.  
  Microarray analysis measures the global expression of 
genes and can provide insight into the genetic programs ex-
pressed in stem cells. Microarrays can also be used to ex-
plore changes in gene expression during stem cell differen-
tiation. Profiling stem cell differentiation in a lineage-
specific and temporal-dependent manner may enable one to 
dissect the genetic wiring of differentiation. This review 
summarizes the methods used to study the expression pro-
files of stem cells and their differentiated derivatives and 
discusses possible mechanisms of stem cell differentiation.  
METHODS TO CHARACTERIZE GENE EXPRES-
SION PROFILES OF STEM CELLS 
  With the ability to monitor the expression levels of al-
most every known and unknown gene, Affymetrix GeneChip 
technology is one of the most popular platform to study gene 
expression profiling [2, 3]. GeneChips are miniature plat-
forms with approximately one million 25 base nucleotide 
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of 47,000 transcripts and variants including 38,500 well 
characterized human genes (HG-U133 Plus 2.0, 
www.affymetrix.com). The comercial platforms and their 
standardize protocols together with the ability to download 
of raw data allows one to reanalyze data generated in other 
studies for further exploration. For example, Stembase is a 
database of microarrays on stem cells and their derivatives to 
search novel stem cell markers and to search for genes that 
have unique functions in stem cells [4]. 
  A simple microarray experiment looks for changes in 
gene expression at distinct timepoints of differentiation. 
Studies that characterize the progression of stem cells into 
specific lineages can be divided into two types of analysis; 
direct and indirect comparisons. The direct comparison, for 
example, compares sample A to sample B, and identifies 
genes that are differentially expressed between two samples 
[5]. This approach is biased towards the identification of 
genes that display the most pronounce differential expression 
between two samples however, genes that are expressed but 
have subtle changes in gene expression are ignored. On the 
other hand, microarrays can be use to define the molecular 
phenotype of a cell. Conventional analysis uses MAS5 (Mi-
croarray Suite version 5.0) algorithm for generating lists of 
genes that are present or absent but has been criticized for 
high false positive rates from exaggerated variances of genes 
with low levels of expression [6]. The reference design, or 
indirect comparison, is used because gene expression values 
can be meaningful in a relative sense [7]. Comparing stem 
cells to a reference file identifies genes that are over-
expressed in stem cells with reference to a cell type. Genes 
that are over-expressed in stem cells could be considered as a 
genetic signature of stem cells. An alternative to MAS is 
Robust Multi-chip Average (RMA). Unlike MAS5, RMA 
identifies differentially expressed genes by comparing two 
cell types and reduces the variances of low intensity genes.  
  The reference design approach has been widely used to 
characterize the changes in gene expression during embry-
onic stem cell differentiation. However, the type of reference 
materials varies from mixed RNA to RNA from a homoge-
neous cell type. The reference design was used to compare 
ESC profiles to a mixture of RNA obtained from various 
adult cells (universal RNA) [8]. This reference point is sup-
posed to represent a signature of differentiated adult cells. 
Since microarrays assess the total RNA within a sample, 
microarrays containing a heterogeneous samples from mix-
tures may influenced by the predominating cell type. An-
other approach is to compared the ES profile to a single dif-
ferentiated cell type, keratinocytes, to identify genes that are 
unique for ESC [8, 9].  
INSIGHTS INTO THE MECHANISM OF STEM CELL 
DIFFERENTIATION  
  Stem cells are an ideal resource for regenerative medi-
cine. Despite the knowledge gained by stem cells’ ability to 
differentiate into multiple lineages, very little is known about 
the genes that govern the special properties of stem cells. 
Stem cells have been previously thought of as a “blank” cell 
and the activation of lineage-specific programs indicates 
commitment into a particular lineage. However, it has been 
shown that embryonic stem cells express more genes than 
their differentiated derivatives [9]. In addition, studies have 
shown that various types of stem cells express low levels of 
genes associated with multiple lineages prior to differentia-
tion, a phenomenon known as “lineage priming” [10]. It is 
unclear whether the expression is due to non-specific hyper-
transcription or to allow a rapid up-regulation of a single 
lineage program when cells differentiate into a particular 
lineage [11].  
EMBRYONIC STEM CELLS EXPRESS TISSUE-
SPECIFIC GENES  
  Embryonic stem cells are a source of pluripotent stem 
cells that can be used for regenerative medicine. Unlike adult 
stem cells, embryonic stem cells have been shown to differ-
entiate into at least 200 somatic cell types, such as dopa-
minergic neurons and beta islet cells [12, 13]. Embryonic 
stem cells (ESCs) are derived from the inner cell mass at the 
blastocyst stage of a fertilized embryo. ESCs have the ability 
to differentiate into all somatic cell types of an organism. In 
addition, ESCs possess the ability to self-renewal indefi-
nitely and provides an unlimited source of cells for cell ther-
apy. Since the inner cell mass is obtained by immuno-
isolation, the isolation of ESCs destroy the embryo. This has 
stimulated research on generating alternative sources of 
pluripotent stem cells. It has been recently shown that adult 
fibroblasts can be reprogrammed into pluripotent stem cells 
(iPS) by exogenous transcription factors. Although the prop-
erties of iPS cells have been compared to those of ESCs, the 
gold standard, a better understanding of ESCs is needed be-
fore they can be compared to iPS and their clinical potential.  
  Initial efforts have been made to define “stemness,” a set 
of genes that are commonly expressed in multiple stem cell 
types, to provide insight underlying self-renewal and the 
ability to differentiate into multiple lineages [14]. However, 
ascribing stem cell functions from gene lists is analogous to 
taking a car apart and explaining how it works. This ap-
proach focuses on the genes themselves rather than decipher-
ing potential mechanisms of stem cell differentiation. Rather 
than identifying genes that are common between multiple 
stem cell types, a better approach is to characterize individ-
ual stem cell types in order to gain a better understanding of 
a stem cell identity.  
  Microarrays were used to identify a molecular signature 
of ESCs by profiling 6 human ESC lines (Bhattacharya 
2004). Using arrays that were fabricated in-house by spotting 
oligonucleotides, gene expression patterns of ESC lines were 
compared to expression patterns of human universal RNA. 
Hierarchical clustering analysis, which is an unsupervised 
method to find biologically significant patterns of gene ex-
pression, showed that 6 ESC lines clustered tightly together, 
indicating a similar expression profile and express several 
genes known to be expressed in human ES cells including 
OCT4, NANOG, TDGF1, GALALIN, CONNEXIN 43. 
Some known markers of undifferentiated ES cells did not 
meet the cutoff criterion (expression in all 6 lines). These 
genes included, CD24, DNMT3B, SOX2 were expressed in 
4 cell lines. Interesting, 5 genes thought to be specific for 
differentiation were present at high levels in all 6 ESC lines 
(keratin 8, keratin 18, beta tubulin 5, cardiac actin, and tro-
ponin T1) and were confirmed by RT-PCR. Interestingly, 356    Current Genomics, 2010, Vol. 11, No. 5  Hipp et al. 
some researchers have noted differences in the behavior of 
cell lines [15]. Since this type of analysis identifies genes 
that are enriched in all 6 embryonic stem cell, maybe the 
differences in their behavior could be related to the unique 
expression of genes of each line. The unique expression of 
genes in each line could also be due to the fact that ESCs 
spontaneously differentiate and that tissue-specific gene ex-
pression could be due to the contamination of differentiated 
ESCs.  
  Another study used microarrays to study the genetic pro-
grams expressed in human ESCs by comparing transcrip-
tional profiles of ESC to progenitor and mature cells of the 
hemapoietic and ketatinocytic lineages to provide snapshots 
of differentiation [9]. Using affymetrix arrays and MAS5, 
4,450 probesets were detected as significantly expressed in 
ESCs while 3,000 probesets were expressed in the differenti-
ated state. This suggests that ESCs express more genes than 
adult cells. Tissue classification of the 4,450 probesets iden-
tified in ESCs showed that 700 probesets are not expressed 
in adult tissues, 3,300 probesets are expressed in multiple 
adult tissues, and around 1000 probe sets are tissue-specific 
genes.  
  Elevated transcriptional activity has been observed in 
embryonic stem cells (Efroni S, 2008). Here, transcriptional 
activity, measured by [H3] uridine incorporation in ESCs 
and 7 day neural progenitor cells (NPCs) derived from ESCs, 
were almost 2-fold higher in ESCs compared to NPCs. In 
addition, the transcriptional status of several tissue-specific 
genes was assessed in ESCs. Transcripts for 11 out of 12 
lineage-restricted genes expressed in ESCs at low levels and 
include actin alpha 1, receptor activator of NF kappa B 
ligand, prostate androgen induced 1, small proline rich pro-
tein 2A, albumin, CD3, CD8, glial fibrillary acidic protein, 
surfactant protein B, uromodulin, synaptotagmin 1, myo-
genin). In addition, they compared the transcription levels of 
tissue-specific genes at different stages of neuronal differen-
tiation and found that levels of transcription decreased dur-
ing differentiation. As ESCs progressed into NPCs and post-
mitotic neurons, 8/12 and 5/12 of the transcripts were ex-
pressed respectively. Protein was not detected by western 
blot analysis. The data suggests that as stem cells differenti-
ate into more mature cells, the expression of multiple tissue-
specific genes decreases. 
Hematopoietic Stem Cells 
  Promiscuous genes have also been observed in the hema-
topoietic system, where expression of genes of multiple line-
ages was detected prior to commitment [16]. The hema-
topoietic system is the best studied stem cell system, demon-
strating the stage-specific steps of differentiation of HSCs 
into multiple lineages and their ability to repopulate the en-
tire hematopoietic system from a single cell. Molecular 
analysis at each step of differentiation has identified several 
crucial regulators, transcription factors and genes as HSC 
differentiate into each hematopoietic lineage. It is unclear 
how undifferentiated HSC can maintain their ability to dif-
ferentiate into mutliple lineages. To test the hypothesis that 
HSC are primed to express multiple lineage-affiliated pro-
grams, Hu et al. showed that HSC express erythroid (globin) 
and myeloid (myeloperoxidase) gene expression programs 
by single cell RT-PCR. Further analysis of globin and mye-
loperoxidase gene expression was assessed in more differen-
tiated cell types. Globin was expressed in erythroid-
committed cells but not myeloid-committed cells, likewise, 
myeloperoxidase was expressed in myeloid-committed cells 
but not erythroid-committed cells. This data suggests that as 
cells commit to a specific lineage, their promiscuity for mul-
tiple lineages disappears. This supports the idea that primi-
tive stem cells express a more diverse set of lineage pro-
grams and the number of lineages decrease as cell become 
more committed into a specific lineage.  
  Since single cell analysis are limited to analysis of selec-
tive set of genes, a global view of gene expression profiles 
can provide insight into the molecular components involved 
in differentiation. However, few studies have performed mi-
croarray analysis on single cells after RNA amplification. 
But one of the limitation RNA amplification is its 3’ bias, 
laborious, and has the potential to distort relative transcript 
abundances [17]. Thus, microarray analysis of purified 
clonal populations of HSCs can provide insights into the 
global gene expression profiles of HSCs. Akashi et al. pro-
filed purified HSCs, non-self-renewing multipotential pro-
genitors (MPPs) and lineage-restricted (common lymphoid 
progenitors) CLPs and common myeloid progenitors (CMPs) 
[18]. HSCs expressed genes specific to nonhematopoietic 
tissues including brain, liver, heart, kidney, muscle, and en-
dothelium. The number of genes specific to nonhema-
topoietic tissues decreased in MPPs, CMPs and CLPs. 
  Are stem cells that are primed really stem cells or par-
tially differentiated? Ye et al. generated a cre-lox approach 
to follow the fate of HSCs that expressed a lineage-affiliated 
marker [19]. Mice were generated with a yellow fluorescent 
protein in the lysozyme gene, which is highly expressed in 
myeolomonocytic cells. Using in vivo lineage tracing tech-
nique, it was shown that lysozyme is expressed at low levels 
in a subset of HSCs and are capable of long-term repopula-
tion potential. This suggests that the expression of a myeloid 
gene does not abolish their stem cell potential.  
Transdifferentiation 
  Transdifferentiation is a process where a cell is commit-
ted towards one lineage switches into a cell type of a differ-
ent lineage. The ability for a mature cell to change pheno-
types has remained controversial because of cell fusion and 
progenitor cell contamination. Using mesenchymal stem 
cells as a model to study transdifferentiation, Song et al. 
showed that fully differentiated osteoblast derived from 
MSCs were capable of differentiating into adipocytes and 
chondrocytes [20]. To ensure that the osteogenic differentia-
tion of MSCs did not result in mixed phenotypes and were 
not contaminated with progenitor cells, MSCs were trans-
fected with GFP driven by the osteocalcin promoter and 
sorted by fluorescence activated cell sorting (FASC). Al-
though only 5% of the cells expressed GFP, all cells ex-
pressed alkaline phosphatase activity. When cells were in-
duced into a chondrogenic lineage, 97% of the cells stained 
positive for collagen II and proteoglycan link proteins. This 
data suggest that fully differentiated cells can switch pheno-
type in response to environmental signals.  
  Other types of stem cells have also exhibited lineage 
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genic and stem cell markers but are negative for hemato-
poeitic markers (c-kit, CD45) and other blood-lineage mark-
ers (Mac-1, Gr-1, CD3, CD4, CD5, CD8) [21]. MDSCs can 
differentiate into myotubes and hematopoietic cell types [22] 
but its not clear whether MDSCs preserve their myogenic 
potential after differentiation into hematopoietic lineages. It 
was determined that MDSCs were able to repopulate the 
bone marrow of lethally irradiated mice. Donor MDSCs-
derived hematopoietic cells that were isolated from bone 
marrow of the recipient animals and purified by the expres-
sion of the neomycin resistance gene were still able to form 
myotubes in vitro and in vivo. Thus, these MDSCs were able 
to preserve their myogenic potential after transplantation 
when isolated from the bone marrow of primary recipient 
mice and retransplanted into the skeletal muscle of a secon-
dary recipient mice.  
CONCLUSIONS 
  While low expression of lineage-specific genes may not 
inhibit differentiation into other lineages, it is difficult to 
determine the expression levels that are necessary to induce 
stem cells into a particular pathway for a specific lineage. 
The over expression of MYC, OCT4, SOX2 and KLF4 has 
been shown to reprogram fully differentiated cells into pluri-
potent stem cells, and up to 20 viral integrations are present 
in each clone [23]. On the other side of the spectrum, recom-
binant HoxB4 fusion proteins can be used to push embryonic 
stem cells towards a hematopoietic lineage [24]. The overex-
pression of genes can also change phenotypes but again, it is 
not clear what level of expression is necessary. A recent 
study showed that the dose-dependent effect of OCT4 ex-
pression has dual effects; basal levels of OCT4 while the up-
regulation of Oct4 induces a cardiogenic fate by turning on 
Sox17, Hex, Wnt3a and BMP2 [25]. This suggests that the 
dosage of Oct4 is critical for maintaining pluripotency or 
driving cells into a more differentiated state.  
  Microarrays are a common technique to characterize the 
molecular signatures of stem cells. A newer and more com-
prehensive approach to analyze transcription is RNA se-
quencing. Sequencing the RNA content of cells can provide 
information to quantify gene expression and identify single-
nucleotide polymorphism (SNP), novel transcripts, novel 
isoforms, and rare transcripts in a single experiment [26,27]. 
Sequence data is mapped to a reference genome and counted, 
thus the total number of “reads” for a given transcript is pro-
portional to the expression level of RNA. Since quantifica-
tion is based on direct sequencing rather than hybridization 
of fluorescent probes, low abundant transcript can be reliably 
identified due to the low background noise of RNA sequenc-
ing [28]. Sequencing-based approaches have the advantage 
of identifying both known and unknown genes in contrast to 
microarrays, where oliogonucloetides must be present on the 
platform. However, limitations of RNA sequencing include 
the high cost and long turnaround time. Yet, the comprehen-
sive genomic information obtained from RNA sequencing is 
enormous and may outweigh these deficiencies.  
  Before stem cells can be used as any type of clinical ther-
apy, strict guidelines must be established to ensure the qual-
ity of the cells, the specificity of differentiation, and the as-
sessment of mixed phenotypes. While lineage-specific gene 
expression and cell surface markers are commonly used to 
describe a differentiated phenotype, global gene expression 
profiling is necessary to provide a non-biased evaluation of 
the quality of cells. Genome-wide characterization of stem 
cells suggests that stem cell express genes that represent 
multiple lineage-specific programs. Thus, the molecular ba-
sis of stem cells appears to entail a promiscuous gene ex-
pression pattern and the expression of these multiple lineage-
specific programs may reflect the potential of stem cells to 
development into these lineages. The therapeutic potential of 
stem cells largely relies on understanding the molecular sig-
nature of stem cells and their derivatives.  
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